STOCK TITAN
  1. Home
  2. Sec-filings
  3. SKIN
  4. [Form 4] The Beauty Health Company Insider Trading Activity

Beauty Health (SKIN) Form 4: Schillinger Receives 73k RSUs

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Beauty Health Company (SKIN) – Form 4 insider filing

Director Doug K. Schillinger reported the grant of 73,051 restricted stock units (RSUs) on 16 Jun 2025. The award is coded "A" (acquisition) and is part of the company’s director compensation program rather than an open-market purchase. Vesting occurs on the earlier of (i) the one-year anniversary of the grant or (ii) the 2026 annual shareholders’ meeting, subject to the director’s continued board service.

Following this grant, Schillinger’s total beneficial ownership increased to 216,035 Class A common shares, all held directly. No derivative securities were reported.

The filing signals continued equity-based alignment between the board and shareholders but does not, by itself, alter Beauty Health’s financial outlook or capital structure.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine RSU grant; modestly positive for alignment, immaterial to valuation.

The transaction is a standard non-cash equity award to a non-executive director. Such grants encourage long-term oversight by tying compensation to share performance, a governance best practice. The additional 73 k shares lift the director’s stake to 216 k shares—meaningful personally but negligible (<0.1%) relative to SKIN’s ~135 m basic shares outstanding. No red flags on timing, pricing, or accelerated vesting clauses. Investors should view the filing as neutral-to-slightly positive for board-shareholder alignment, with no direct earnings or cash-flow impact.

TL;DR: Insider award, not a buy; unlikely to move SKIN stock.

Because the RSUs were granted, not purchased, the filing does not reflect market sentiment or signal undervaluation. Liquidity impact is immaterial: even when fully vested, dilution is less than 0.1%. Investors focusing on catalysts such as Hydrafacial sales trends, margin recovery, or debt covenants should not treat this Form 4 as a trading event. Overall impact on valuation models: none.

Insider Schillinger Doug K.
Role Director
Type Security Shares Price Value
Grant/Award Class A Common Stock 73,051 $0.00 $0.00
Holdings After Transaction: Class A Common Stock — 216,035 shares (Direct)
Footnotes (1)
  1. F1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

How many shares did Doug K. Schillinger acquire in the Form 4?
He received 73,051 restricted stock units on 16 Jun 2025.

What is the vesting schedule for the RSUs reported by SKIN?
The RSUs vest on the earlier of the one-year anniversary of the grant or the 2026 annual shareholders’ meeting, contingent on continued board service.

How many Beauty Health (SKIN) shares does Schillinger own after the transaction?
His total beneficial ownership increased to 216,035 Class A common shares.

Does the Form 4 indicate an open-market purchase?
No. The filing records an equity award, not a market purchase; therefore, it does not signal personal bullishness.

Will the RSU grant materially dilute existing SKIN shareholders?
Dilution is immaterial; 73 k shares represent far less than 0.1% of SKIN’s outstanding shares.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schillinger Doug K.
(Last) (First) (Middle)
C/O THE BEAUTY HEALTH COMPANY
2165 SPRING STREET
(Street)
LONG BEACH CA 90806
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/16/2025 A(1) 73,051 A(1) (1) 216,035 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time.
Remarks:
/s/ Doug K. Schillinger 06/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR